Company:DeepIntent
DeepIntent is an advertising technology company that built a programmatic advertising platform for pharmaceutical and life science companies to reach healthcare providers and patients with relevant, HIPAA-compliant digital advertising. The company was founded in 2016 in New York City by former Memorial Sloan Kettering Cancer Center data scientists who believed that advertising technology and data science can measurably improve the lives of patients.
History
DeepIntent was founded by Chris Paquette[1], its current CEO, in April 2016. After graduating with a degree in bioengineering from SUNY Binghamton, Paquette got a job in advertising technology before working as a data scientist for Memorial Sloan Kettering.
Inspired by his father’s cancer misdiagnosis 14 years earlier, Paquette founded DeepIntent to get relevant information to patients in a timely manner so they can have more informed conversations with their doctors.
In September 2019, DeepIntent announced the launch of MarketMatch[2], now known as the DeepIntent Healthcare Advertising Platform.
Since then, DeepIntent has launched additional products and product updates, including Patient Modeled Audiences[3] in June 2020, the healthcare industry’s first Connected TV Marketplace[4] in August of 2020, DeepIntent Outcomes™[5] in April of 2021, and Audience Marketplace[6] in September of 2021.
DeepIntent was granted a patent[7] in July of 2021 for its demand side platform’s ability to connect real-world clinical data with ad impression data to measure and optimize live ad campaigns and measure impact on prescription performance metrics such as audience quality, total prescriptions, new prescription, and new-to-brand prescriptions. In December 2021, DeepIntent was granted another patent for its HIPAA-compliant Patient Modeled Audiences[8] technology, which determines the correlation between demographics and disease to create precise, campaign-specific modeled audiences.
In December 2021, DeepIntent formed a partnership with LG Ads Solutions as its exclusive healthcare demand side platform[9].
Services
DeepIntent enables healthcare and pharmaceutical marketers to run entire programmatic advertising campaigns with a single platform. They can create HIPAA-compliant patient audiences; select digital media formats, such as online video, display, connected TV, and audio; and optimize their campaigns toward prescription performance metrics including audience quality, total prescriptions, new prescription, and new-to-brand prescriptions.
References
- ↑ "Medical Marketing and Media". https://www.mmm-online.com/welcome/83508/single/~40-under-40~mmm-40-under-40-2021/.
- ↑ "Error: no
|title=specified when using {{Cite web}}". https://www.bloomberg.com/press-releases/2019-09-18/deepintent-achieves-the-industry-s-first-true-1-1-marketing-solution-for-healthcare-and-pharmaceutical-brands. - ↑ "Error: no
|title=specified when using {{Cite web}}". https://www.pm360online.com/pm360-2020-innovative-product-patient-modeled-audiences-from-deepintent/. - ↑ "Error: no
|title=specified when using {{Cite web}}". https://www.adexchanger.com/tv-and-video/tackling-the-challenge-of-healthcare-marketing-in-ctv/. - ↑ "Martech Series". https://martechseries.com/analytics/audience-data/deepintent-outcomes-named-by-pm360-as-one-of-the-most-innovative-products-of-2021/.
- ↑ "Error: no
|title=specified when using {{Cite web}}". https://markets.businessinsider.com/news/stocks/deepintent-launches-the-first-data-rich-privacy-safe-digital-marketplace-for-healthcare-advertising-1029192979. - ↑ "Medical Marketing Media". https://www.mmm-online.com/home/channel/deepintent-fine-tunes-tech-to-optimize-ad-campaigns-boost-script-lift/.
- ↑ "Error: no
|title=specified when using {{Cite web}}". https://www.pharmexec.com/view/deepintent-receives-patent-for-technology-that-enables-marketers-to-reach-precise-patient-populations-in-a-hipaa-compliant-privacy-safe-manner. - ↑ "LG Ads Solutions". https://lgads.tv/lg-ads-solutions-names-deepintent-exclusive-dsp-for-healthcare-ctv-ads/.
 |  |
